Emgality and Increased tendency to bruise - a phase IV clinical study of FDA data

Summary:

Increased tendency to bruise is reported as a side effect among people who take Emgality (galcanezumab-gnlm), especially for people who are female, 50-59 old, also take Maxalt, and have Migraine.

The phase IV clinical study analyzes which people have Increased tendency to bruise when taking Emgality. It is created by eHealthMe based on reports of 24,623 people who have side effects when taking Emgality from the FDA, and is updated regularly.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

What is Increased tendency to bruise?

Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone) is found to be associated with 768 drugs and 813 conditions by eHealthMe. Check the latest studies of Increased tendency to bruise.

On Aug, 08, 2026

24,623 people reported to have side effects when taking Emgality.
Among them, 12 people (0.05%) have Increased tendency to bruise.

Could Emgality cause Increased tendency to bruise?

Among these 12 people:

What is the gender of people who have Increased tendency to bruise when taking Emgality? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Increased tendency to bruise when taking Emgality? *

What are other drugs people take besides Emgality? *

What are other side effects people have besides Increased tendency to bruise? *

Migraine (headache): 5 people, 41.67%
Fatigue (feeling of tiredness): 4 people, 33.33%
Insomnia (sleeplessness): 4 people, 33.33%
Panic Disorder: 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Stress And Anxiety: 3 people, 25.00%
Injection Site Bruising: 3 people, 25.00%
Headache (pain in head): 3 people, 25.00%
Itching: 2 people, 16.67%
Weight Decreased: 2 people, 16.67%

What are the existing conditions these people have? *

Migraine (headache): 8 people, 66.67%
Stress And Anxiety: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Insomnia (sleeplessness): 2 people, 16.67%
Hypersensitivity: 2 people, 16.67%
Blood Testosterone Increased: 2 people, 16.67%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 2 people, 16.67%
Appetite Disorder (abnormal eating habits): 2 people, 16.67%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 2 people, 16.67%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Emgality and have Increased tendency to bruise?

- Check whether Increased tendency to bruise is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emgality:

Emgality (24,702 reports)

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Increased tendency to bruise:

Increased tendency to bruise (768 drugs)

Browse all the conditions that are associated with Increased tendency to bruise:

Increased tendency to bruise (813 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on galcanezumab-gnlm (the active ingredients of Emgality) and Emgality (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.